Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-18 | Crinetics Pharmaceuticals, Inc. | Struthers Richard...
(President & CEO) |
G | Common Stock | D | 350 | $0.00 - $0.00 | $0 |
| 2024-04-15 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
S | Common Stock | D | 14375 | $44.47 - $44.47 | $639,256 |
| 2024-04-15 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
M | Common Stock | A | 14375 | $16.89 - $16.89 | $242,793 |
| 2024-04-04 | Crinetics Pharmaceuticals, Inc. | Struthers Richard...
(President & CEO) |
S | Common Stock | D | 40951 | $49.17 - $49.17 | $2,013,560 |
| 2024-04-04 | Crinetics Pharmaceuticals, Inc. | Struthers Richard...
(President & CEO) |
M | Common Stock | A | 40951 | $9.28 - $9.28 | $380,025 |
| 2024-03-20 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
S | Common Stock | D | 15089 | $43.28 - $45.89 | $664,762 |
| 2024-03-20 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
M | Common Stock | A | 14375 | $16.89 - $16.89 | $242,793 |
| 2024-03-18 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
F | Common Stock | D | 411 | $38.14 - $38.14 | $15,675 |
| 2024-03-18 | Crinetics Pharmaceuticals, Inc. | Knight Jeff E.
(Chief Operating Officer) |
F | Common Stock | D | 4283 | $38.14 - $38.14 | $163,353 |
| 2024-03-18 | Crinetics Pharmaceuticals, Inc. | Hassard James
(Chief Commercial Officer) |
F | Common Stock | D | 1741 | $38.14 - $38.14 | $66,401 |
| 2024-03-18 | Crinetics Pharmaceuticals, Inc. | Betz Stephen F.
(Chief Scientific Officer) |
F | Common Stock | D | 3655 | $38.14 - $38.14 | $139,401 |
| 2024-03-19 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
S | Common Stock | D | 6942 | $42.91 - $42.91 | $297,881 |
| 2024-03-18 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
F | Common Stock | D | 3983 | $38.14 - $38.14 | $151,911 |
| 2024-03-18 | Crinetics Pharmaceuticals, Inc. | Struthers Richard...
(President & CEO) |
F | Common Stock | D | 12687 | $38.14 - $38.14 | $483,882 |
| 2024-03-04 | Crinetics Pharmaceuticals, Inc. | Hassard James
(Chief Commercial Officer) |
A | Common Stock | A | 17000 | $0.00 - $0.00 | $0 |
| 2024-03-04 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
A | Common Stock | A | 25500 | $0.00 - $0.00 | $0 |
| 2024-03-04 | Crinetics Pharmaceuticals, Inc. | Struthers Richard...
(President & CEO) |
A | Common Stock | A | 65000 | $0.00 - $0.00 | $0 |
| 2024-03-04 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
A | Common Stock | A | 23000 | $0.00 - $0.00 | $0 |
| 2024-03-04 | Crinetics Pharmaceuticals, Inc. | Knight Jeff E.
(Chief Operating Officer) |
A | Common Stock | A | 23000 | $0.00 - $0.00 | $0 |
| 2024-03-04 | Crinetics Pharmaceuticals, Inc. | Betz Stephen F.
(Chief Scientific Officer) |
A | Common Stock | A | 23000 | $0.00 - $0.00 | $0 |
| 2024-02-12 | Crinetics Pharmaceuticals, Inc. | Struthers Richard...
(President & CEO) |
G | Common Stock | D | 120000 | $0.00 - $0.00 | $0 |
| 2024-01-25 | Crinetics Pharmaceuticals, Inc. | Betz Stephen F.
(Chief Scientific Officer) |
S | Common Stock | D | 3000 | $37.26 - $37.26 | $111,780 |
| 2024-01-02 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
S | Common Stock | D | 10000 | $35.47 - $35.47 | $354,700 |
| 2024-01-02 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
M | Common Stock | A | 10000 | $9.28 - $9.28 | $92,800 |
| 2023-11-02 | Crinetics Pharmaceuticals, Inc. | Struthers Richard...
(President & CEO) |
S | Common Stock | D | 200000 | $29.95 - $30.56 | $6,111,439 |
| 2023-11-02 | Crinetics Pharmaceuticals, Inc. | Struthers Richard...
(President & CEO) |
M | Common Stock | A | 200000 | $9.28 - $9.28 | $1,855,999 |
| 2023-11-01 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
S | Common Stock | D | 10000 | $28.75 - $28.75 | $287,500 |
| 2023-11-01 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
M | Common Stock | A | 10000 | $9.28 - $9.28 | $92,800 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |